Unichem gets US FDA nod for Pithampur bulk drug unit
2009 November 10
Unichem Laboratories has informed that the company has received approval for its bulk drug [API] facility situated at Pithampur from US FDA. With this approval, both bulk drug facilities situated at Roha, Maharashtra and Pithampur, Madhya Pradesh are duly approved by US FDA. The company’s formulation facilities at Goa and Ghaziabad are already approved by US FDA.
Related posts:
- Orchid chemicals shares buoyant Stock markets in today’s trading in shares of orchids Chemicals trend looks fast. Bombay...
- Natko Pharma continues today Stock markets climb a series of Natko Pharma continues today. Bombay Stock Exchange (BSE)...
- Wockhardt touched 6 mths high Wockhardt touched 6 months high in today’s trade. The company got US FDA nod for...
- Madhya Pradesh Board of Secondary Education Results 2009 Madhya Pradesh Board of Secondary Education publishes class 12th supplementary examination Results 2009 CLICK HERE...
- US Court rules Ranbaxy’s generic valganciclovir does not infringe Roche’s Valcyte patent In a verdict on the patent litigation between Roche Palo Alto and the Daiichi-Ranbaxy on...
Subscribe to Stock Market Today